AJP - Endo Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 296: E985-E992, 2009. First published February 17, 2009; doi:10.1152/ajpendo.00004.2009
0193-1849/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/5/E985    most recent
00004.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leturque, A.
Right arrow Articles by Le Gall, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leturque, A.
Right arrow Articles by Le Gall, M.

REVIEWS

GLUT2 mutations, translocation, and receptor function in diet sugar managing

Armelle Leturque, Edith Brot-Laroche, and Maude Le Gall

Centre de recherche des Cordeliers, Institut National de la Santé et de la Recherche Médicale UMR S-872; Université Pierre et Marie Curie-Paris, 6 UMR S-872; and Centre National de la Recherche Scientifique UMR S-872, Paris, France

Submitted 5 January 2009 ; accepted in final form 9 February 2009

ABSTRACT

Cloned 20 years ago, GLUT2 is a facilitative glucose transporter in the liver, pancreas, intestine, kidney, and brain. It ensures large bidirectional fluxes of glucose in and out the cell due to its low affinity and high capacity. It also transports other dietary sugars, such as fructose and galactose, within the range of physiological concentrations. Sugars and hormones regulate its gene expression. The contribution of GLUT2 to human metabolic diseases previously appeared modest. However, in the past decade, three major features of the GLUT2 protein have been revealed. First, GLUT2 mutations cause the severe but rare Fanconi-Bickel syndrome, mainly characterized by glycogenosis. Recently, a GLUT2 polymorphism has been associated with preferences for sugary food. Second, the GLUT2 location at the cell surface is regulated; this governs cellular activities dependent on glucose in the intestine and possibly those in the liver and pancreas. For instance, GLUT2 translocation from an intracellular pool to the apical membrane after a sugar meal transiently increases sugar uptake by enterocytes (reviewed in 32). Third, GLUT2 functions as a membrane receptor of sugar. Independently of glucose metabolism, GLUT2 detects the presence of extracellular sugar and transduces a signal to modulate cell functions, including β-cell insulin secretion, renal reabsorption, and intestinal absorption according to the sugar environment. These recent developments are examined here in heath and metabolic disease, highlighting various unanswered questions.

glucose transporter 2; Fanconi-Bickel syndrome; pancreas; apical membrane; sugar sensing



Address for reprint requests and other correspondence: A. Leturque, Centre de recherche des Cordeliers 15 rue de l'école de médecine, F-75006 Paris, France (E-mail: armelle.leturque{at}crc.jussieu.fr)




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
T. Ueda, T. Furusawa, T. Kurahashi, L. Tessarollo, and M. Bustin
The Nucleosome Binding Protein HMGN3 Modulates the Transcription Profile of Pancreatic {beta} Cells and Affects Insulin Secretion
Mol. Cell. Biol., October 1, 2009; 29(19): 5264 - 5276.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.